This is a data page. Include references and links to the source of your data.
Jan 26 (Reuters) – New data from one U.S. Centers for Disease Control and Prevention (CDC) database shows a possible stroke risk link for older adults who received an updated Pfizer (PFE.N)/BioNTech (22UAy.DE) COVID-19 booster shot, but the signal is weaker than what the agency had flagged earlier in January, health officials said on Thursday.
U.S. Food and Drug Administration officials said they had not detected a link between the shots and strokes in two other safety monitoring databases.
The new data was presented at a meeting of outside experts that advise the FDA on vaccine policy.
Earlier this month, U.S. health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots in its Vaccine Safety Datalink (VSD) database. They said at the time it was very unlikely to represent a true clinical risk.
Dr. Nicola Klein of healthcare company Kaiser Permanente, which maintains VSD data for the CDC, said the rate of strokes observed in the database had slowed in recent weeks, but the signal was still statistically significant, meaning likely not by chance.
https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-still-looking-potential-stroke-risk-pfizer-bivalent-covid-shot-2023-01-26/
February, 1 2023
A U.S. judge approved a multimillion-dollar settlement for workers who were fired by an Illinois healthcare system for refusing to get a COVID-19 vaccine.
A U.S. judge approved a multimillion-dollar settlement on Dec. 19 for workers who were fired by an Illinois healthcare system for refusing to get a COVID-19 vaccine.
About 500 workers who were terminated or, after seeing their exemption requests denied, got a COVID-19 vaccine, will receive compensation as part of the $10.3 million settlement, a preliminary version of which was first announced in July.
Read Full Article Below:
500 Healthcare Workers Get $10 Million Settlement After Being Fired Over COVID Vaccine Mandate
December, 21 2022
HEALTH AND SCIENCE
FDA pulls Covid antibody treatment because it’s not effective against dominant omicron variants
KEY POINTS
The FDA, in a notice Wednesday, said bebtelovimab is no longer authorized for use because it is not expected to neutralize the omicron BQ.1 and BQ.1.1 subvariants.
U.S. health officials have warned that people with weak immune systems face a heightened risk from Covid this winter, because omicron subvariants threaten to knock out antibody treatments.
President Joe Biden has called on people with weak immune systems to consult with their physicians about what extra precautions they should take this winter to stay safe.
https://www.cnbc.com/2022/12/01/covid-fda-pulls-antibody-bebtelovimab-because-not-effective-against-omicron-bqpoint1.html
December, 8 2022